Anuh Pharma Ltd
ANUHPHR
Company Profile
Business description
Anuh Pharma Ltd is engaged in the business of manufacturing and selling of Bulk drugs and chemicals. Geographically, it derives a majority of revenue from India. Its product categories include macrolides, anti-TB, anti-malarial, anti-bacterial, anti-hypertension, expectorant, quinolones, and others. The company generates revenue from the sale of Branded Prescription drugs, Over-the-Counter (OTC) drugs and Generic Prescription drugs.
Contact
Dr. Annie Besant Road
North Wing, 3-A, Shiv Sagar Estate
Worli
MumbaiMH400 018
INDT: +91 2266227575
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
295
Stocks News & Analysis
stocks
US utilities stocks keep rallying as investors bet on power demand growth
Rising electricity demand from data centers supports earnings growth, but Morningstar analysts say the sector looks less attractive after a sharp rally.
stocks
What did Morningstar subscribers buy and sell during March?
How the most traded shares in March stack up against our analysts views.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,165.10 | 41.30 | -0.45% |
| CAC 40 | 8,308.41 | 72.43 | 0.88% |
| DAX 40 | 24,055.30 | 312.86 | 1.32% |
| Dow JONES (US) | 48,429.47 | 211.22 | 0.44% |
| FTSE 100 | 10,593.06 | 10.10 | 0.10% |
| HKSE | 25,872.32 | 211.47 | 0.82% |
| NASDAQ | 23,444.14 | 260.41 | 1.12% |
| Nikkei 225 | 57,877.39 | 1,374.62 | 2.43% |
| NZX 50 Index | 13,017.26 | 2.92 | -0.02% |
| S&P 500 | 6,932.46 | 46.22 | 0.67% |
| S&P/ASX 200 | 8,970.80 | 43.20 | -0.48% |
| SSE Composite Index | 4,026.63 | 38.07 | 0.95% |